ArticleExploration of targeted anti-tumor therapy2024

Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer.

Hortense De Saint Basile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.